An assessment of the predictive value of low risk criteria for children with intermittent asthma

Background Current asthma guidelines recommend short acting beta agonist medication (SABA) be used in combination with an inhaled corticosteroid to reduce risk for severe asthma exacerbations. This may not be appropriate for patients at low risk for severe exacerbations. Methods This study is a coho...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric pulmonology 2023-06, Vol.58 (6), p.1651-1657
Main Authors: Farber, Harold J., Silveira, Edwin, Wong, Jackson Y.
Format: Article
Language:English
Subjects:
Administration, Inhalation
Adrenal Cortex Hormones - therapeutic use
Anti-Asthmatic Agents - therapeutic use
Asthma
Asthma - diagnosis
Asthma - drug therapy
Asthma - epidemiology
Child
Cohort analysis
Cohort Studies
cohort study
Emergency medical care
Emergency Service, Hospital
health care utilization
Health services utilization
Humans
risk
short acting beta agonist
Steroids
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Current asthma guidelines recommend short acting beta agonist medication (SABA) be used in combination with an inhaled corticosteroid to reduce risk for severe asthma exacerbations. This may not be appropriate for patients at low risk for severe exacerbations. Methods This study is a cohort study using computerized claims data from Texas Children's Health Plan. Inclusion criteria were members 1 to 0 and ≤2 SABA canister dispensings group (odds ratio: 0.99, 95% confidence interval: 0.54–1.81). Interpretation Asthma patients at low risk for severe exacerbations can be identified. This information can be useful to guide treatment decisions.
ISSN:8755-6863
1099-0496
DOI:10.1002/ppul.26369